Evidence map›Paper›PMID 28161868›Full record

ArticleNeuroscience bulletin2017

Protective Effect of Resveratrol on the Brain in a Rat Model of Epilepsy.

Zhen Li, Zhuyan You, Min Li, Liang Pang, Juan Cheng, Liecheng Wang

Open access · bronzeAbstract read
In one paragraph

Article in Neuroscience bulletin, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. GABAPharmaceuticals (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Review
  7. The Oxidative Stress in Epilepsy-Focus on Melatonin.International journal of molecular sciences · 2024
    Review
  8. Review
  9. Article
  10. Phenolics as GABAMolecules (Basel, Switzerland) · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Zhen LiDepartment of Pharmacology, Anhui Medical University, Hefei, 230032, China.
Zhuyan YouDepartment of Physiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, China.
Min LiDepartment of Physiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, China.
Liang PangDepartment of Physiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, China.
Juan ChengDepartment of Pharmacology, Anhui Medical University, Hefei, 230032, China.
Liecheng WangDepartment of Pharmacology, Anhui Medical University, Hefei, 230032, China. wangliecheng@ahmu.edu.cn.
Anhui Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulating evidence has suggested resveratrol as a promising drug candidate for the treatment of epilepsy. To validate this, we tested the protective effect of resveratrol on a kainic acid (KA)-induced epilepsy model in rats and investigated the underlying mechanism. We found that acute resveratrol application partially inhibited evoked epileptiform discharges in the hippocampal CA1 region. During acute, silent and chronic phases of epilepsy, the expression of hippocampal kainate glutamate receptor (GluK2) and the GABA

Indexed as

CA1 Region, HippocampalEpilepsy, Temporal LobeAnimalsAnticonvulsantsDisease Models, AnimalDown-RegulationExcitatory Amino Acid Agonistsgamma-Aminobutyric AcidGluK2 Kainate ReceptorGlutamic AcidKainic AcidKainic Acid ReceptorsMaleNeuroprotective AgentsRatsRats, WistarAnticonvulsantsExcitatory Amino Acid AgonistsGabra1 protein, ratgamma-Aminobutyric AcidGluK2 Kainate ReceptorGlutamic AcidKainic AcidKainic Acid ReceptorsNeuroprotective AgentsReceptors, GABA-AResveratrolStilbenesEpilepsyGABAGlutamateHippocampusResveratrol

Identifiers

PMID28161868
PMCPMC5567521
OpenAlexW2584414208

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.